000			01979 a2200625 4500
005			20250517211645.0
264		0	_c20181227
008			201812s 0 0 eng d
022			_a1464-3405
024	7		_a10.1016/j.bmcl.2018.04.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aMou, Jianfeng
245	0	0	_aStructure-activity relationship study of a series of caspase inhibitors containing γ-amino acid moiety for treatment of cholestatic liver disease. _h[electronic resource]
260			_bBioorganic & medicinal chemistry letters _c06 2018
300			_a1874-1878 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAmino Acids _xchemistry
650	0	4	_aAnimals
650	0	4	_aBilirubin _xblood
650	0	4	_aBinding Sites
650	0	4	_aCaspase 1 _xchemistry
650	0	4	_aCaspase Inhibitors _xchemistry
650	0	4	_aDisease Models, Animal
650	0	4	_aHalf-Life
650	0	4	_aHumans
650	0	4	_aJurkat Cells
650	0	4	_aLiver Diseases _xdrug therapy
650	0	4	_aMice
650	0	4	_aMolecular Docking Simulation
650	0	4	_aProtein Structure, Tertiary
650	0	4	_aStructure-Activity Relationship
650	0	4	_afas Receptor _xantagonists & inhibitors
700	1		_aWu, Songliang
700	1		_aLuo, Zhi
700	1		_aGuo, Fengying
700	1		_aHe, Haiying
700	1		_aWang, Jianhua
700	1		_aLin, Fusen
700	1		_aGuo, Fengxun
700	1		_aSun, Jianping
700	1		_aShen, Liang
700	1		_aZeng, Minggao
700	1		_aWang, Chuan
700	1		_aXu, Deming
700	1		_aGu, Zhengxian
700	1		_aTian, Xin
700	1		_aZhang, Aiming
700	1		_aXu, Hongjiang
700	1		_aYang, Ling
700	1		_aZhang, Xiquan
700	1		_aLi, Jian
700	1		_aChen, Shuhui
773	0		_tBioorganic & medicinal chemistry letters _gvol. 28 _gno. 10 _gp. 1874-1878
856	4	0	_uhttps://doi.org/10.1016/j.bmcl.2018.04.002 _zAvailable from publisher's website
999			_c28282349 _d28282349